• Flanders Investment & Trade
  • Team Vesalius

Patrick Van Beneden looks back on a long career as partner in leading European investment firm Gimv

Patrick Van Beneden


Associate partner
Karel Oomsstraat 37
2018 Antwerp

There, he built a successful track record in early- and late-stage investments and exits, including DevGen, CropDesign, Plexxikon, Endosense, Crucell, Innogenetics and Ablynx.

Currently, Van Beneden represents Gimv on the boards of biotech/medtech firms JenaValve, Biotalys, Onward and Fire 1. He holds a Masters Degree in Financial Sciences from Vlekho in Brussels.

Team Vesalius visionairies

Flanders’ life sciences industry: the perfect combo of biotech, medtech, pharma and healthcare

Defining Flanders’ life sciences industry as diverse is an understatement. From young start-ups to established local firms and multinationals: the entire value chain – from research and discovery to development and commercialization – is represented in Belgium’s northern region. Thanks to fertile cross-pollination between biotech, medtech, pharmaceuticals and healthcare, Flanders offers a unique life sciences ecosystem that is underpinned by a robust financing landscape and a supportive government. Will your company claim its place in this dynamic hub?